Stratipath news

Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.

Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.

News about Stratipath

Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman

14 August 2024

Swelife conducted an interview with our Chief Medical Officer and

Stratipath was honored with the Dream Award at the Techarenan Challenge in Almedalen.

28 June 2024

Stratipath was honored with the Dream Award at the Techarenan

Seminar – Almedalen. ”AI can predict relapse in breast cancer – How does this affect breast cancer care?”

27 June 2024

Seminar – Almedalen. ”AI can predict relapse in breast cancer

Seminar – Almedalen ”No precision medicine without pathology”

26 June 2024

Seminar – Almedalen ”No precision medicine without pathology”

Stratipath Breast AI-based risk profiling for breast cancer is now available for clinical use in the UK.

1 June 2024

Stratipath Breast, is now officially registered with the Medicines and

Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine

16 May 2024

Stratipath co-founder Professor Johan Hartman, is discussing the future of

Press releases

Professor Jonas Bergh, will be leading our scientific advisory board

24 January 2023

Stratipath is happy to announce that one of the most

The Swedish deep-tech company Stratipath announces its integration with Sectra, one of the most expanding PACS systems for digital pathology

23 August 2022

Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic

First CE-IVD marked AI solution for prognostic risk stratification of breast cancer patients

1 June 2022

Stratipath, a global leader in AI-based precision diagnostic solutions, today

Media coverage

Article in Impact loop.

24 September 2024

“We have the first product in this field approved for

Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman

14 August 2024

Swelife conducted an interview with our Chief Medical Officer and

Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine

16 May 2024

Stratipath co-founder Professor Johan Hartman, is discussing the future of

Follow us: